DK587989A - Farmaceutisk middel indeholdende 1-(mono- eller b is(trifluormethyl)-2-pyridinyl)piperaziner - Google Patents
Farmaceutisk middel indeholdende 1-(mono- eller b is(trifluormethyl)-2-pyridinyl)piperazinerInfo
- Publication number
- DK587989A DK587989A DK587989A DK587989A DK587989A DK 587989 A DK587989 A DK 587989A DK 587989 A DK587989 A DK 587989A DK 587989 A DK587989 A DK 587989A DK 587989 A DK587989 A DK 587989A
- Authority
- DK
- Denmark
- Prior art keywords
- piperazines
- pyridinyl
- trifluoromethyl
- mono
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88402965 | 1988-11-24 | ||
| EP88402965 | 1988-11-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK587989D0 DK587989D0 (da) | 1989-11-22 |
| DK587989A true DK587989A (da) | 1990-05-25 |
| DK175313B1 DK175313B1 (da) | 2004-08-16 |
Family
ID=8200442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198905879A DK175313B1 (da) | 1988-11-24 | 1989-11-22 | Farmaceutisk middel indeholdende 1-[mono- eller bis(trifluormethyl)-2-pyridinyl]piperaziner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4971969A (da) |
| EP (1) | EP0370560B1 (da) |
| JP (1) | JP2873025B2 (da) |
| KR (1) | KR0155543B1 (da) |
| AU (1) | AU621419B2 (da) |
| CA (1) | CA2003665C (da) |
| DE (1) | DE68912282T2 (da) |
| DK (1) | DK175313B1 (da) |
| ES (1) | ES2061953T3 (da) |
| IE (1) | IE62792B1 (da) |
| NZ (1) | NZ231487A (da) |
| ZA (1) | ZA898728B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE911774A1 (en) * | 1990-06-11 | 1991-12-18 | Akzo Nv | Pyridinylpiperazine derivatives |
| US5877183A (en) * | 1996-06-06 | 1999-03-02 | Ergo Research Corporation | Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| CA2257084A1 (en) * | 1996-06-06 | 1997-12-11 | Anthony H. Cincotta | Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| WO1998033504A1 (en) * | 1997-02-03 | 1998-08-06 | Akzo Nobel N.V. | Treatment of urinary incontinence |
| PL203140B1 (pl) | 1997-10-27 | 2009-08-31 | Neurosearch As | Pochodna homopiperazyny, kompozycja farmaceutyczna zawierająca te pochodne i zastosowanie tej pochodnej |
| EP1326837A1 (en) * | 2000-10-13 | 2003-07-16 | Akzo Nobel N.V. | Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| US6498184B2 (en) | 2000-12-05 | 2002-12-24 | Akzo Nobel N.V. | Serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
| EP1213017A3 (en) * | 2000-12-05 | 2003-11-12 | Akzo Nobel N.V. | Use of a 5-HT2C receptor agonist for the treatment of hot flushes |
| SE0201544D0 (sv) * | 2002-05-17 | 2002-05-17 | Biovitrum Ab | Novel compounds and thier use |
| US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| US20040081678A1 (en) * | 2002-08-09 | 2004-04-29 | Anthony Cincotta | Therapeutic process for the treatment of obesity and associated metabolic disorders |
| EA200600071A1 (ru) * | 2003-06-20 | 2006-08-25 | Арена Фармасьютикалз, Инк. | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором |
| EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
| JPWO2006064780A1 (ja) * | 2004-12-14 | 2008-06-12 | 塩野義製薬株式会社 | 便秘治療剤 |
| WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
| ES2375585T3 (es) * | 2007-03-05 | 2012-03-02 | F. Hoffmann-La Roche Ag | Proceso para la s�?ntesis de inhibidores de glyt-1. |
| WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
| US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
| JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5690060A (en) * | 1979-12-24 | 1981-07-21 | Ishihara Sangyo Kaisha Ltd | 2-amino-trifluoromethylpyridine derivative and its preparation |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| FR2573075B1 (fr) * | 1984-09-14 | 1987-03-20 | Innothera Lab Sa | Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique |
| CA1286672C (en) * | 1985-10-16 | 1991-07-23 | Magid A. Abou-Gharbia | Fused bicyclic imides with psychotropic activity |
| FR2611713B1 (fr) * | 1987-02-27 | 1990-11-30 | Adir | Nouveaux derives de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acetique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| US4876256A (en) * | 1988-04-29 | 1989-10-24 | Merck & Co., Inc. | Alkylpiperazinylpyridines as hypoglycemic agents |
-
1989
- 1989-11-14 EP EP89202877A patent/EP0370560B1/en not_active Expired - Lifetime
- 1989-11-14 IE IE365489A patent/IE62792B1/en not_active IP Right Cessation
- 1989-11-14 DE DE89202877T patent/DE68912282T2/de not_active Expired - Fee Related
- 1989-11-14 ES ES89202877T patent/ES2061953T3/es not_active Expired - Lifetime
- 1989-11-15 ZA ZA898728A patent/ZA898728B/xx unknown
- 1989-11-21 AU AU45387/89A patent/AU621419B2/en not_active Ceased
- 1989-11-21 JP JP1303007A patent/JP2873025B2/ja not_active Expired - Fee Related
- 1989-11-21 US US07/439,964 patent/US4971969A/en not_active Expired - Lifetime
- 1989-11-22 DK DK198905879A patent/DK175313B1/da not_active IP Right Cessation
- 1989-11-22 NZ NZ231487A patent/NZ231487A/xx unknown
- 1989-11-23 KR KR1019890017095A patent/KR0155543B1/ko not_active IP Right Cessation
- 1989-11-23 CA CA002003665A patent/CA2003665C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE68912282D1 (de) | 1994-02-24 |
| EP0370560A1 (en) | 1990-05-30 |
| JPH02184672A (ja) | 1990-07-19 |
| CA2003665A1 (en) | 1990-05-24 |
| AU4538789A (en) | 1990-05-31 |
| CA2003665C (en) | 1999-04-06 |
| ZA898728B (en) | 1990-08-29 |
| DK175313B1 (da) | 2004-08-16 |
| KR0155543B1 (ko) | 1998-11-16 |
| DK587989D0 (da) | 1989-11-22 |
| IE62792B1 (en) | 1995-03-08 |
| NZ231487A (en) | 1991-01-29 |
| KR900007419A (ko) | 1990-06-01 |
| US4971969A (en) | 1990-11-20 |
| AU621419B2 (en) | 1992-03-12 |
| DE68912282T2 (de) | 1994-04-28 |
| JP2873025B2 (ja) | 1999-03-24 |
| IE893654L (en) | 1990-05-24 |
| ES2061953T3 (es) | 1994-12-16 |
| EP0370560B1 (en) | 1994-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK587989A (da) | Farmaceutisk middel indeholdende 1-(mono- eller b is(trifluormethyl)-2-pyridinyl)piperaziner | |
| DK462486A (da) | Farmaceutisk tablet indeholdende cefuroxim-axetil | |
| NO306994B1 (no) | Heteroarylpiperidiner, pyrrolidiner og piperaziner, deres anvendelse for fremstilling av antipsykotika og analgetika samt farmasoeytiske preparater inneholdende forbindelsene | |
| NO305802B1 (no) | Nye forbindelser, farmas°ytiske blandinger inneholdende disse og anvendelse av disse forbindelser | |
| ATE178489T1 (de) | Fluessige oral anzuwendende arzneizubereitungen enthaltend paroxetinresinate | |
| DE3579655D1 (de) | Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3. | |
| DK158335C (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater til ekstern anvendelse og indeholdende et ikke-steroidt antiphlogistisk analgetisk middel | |
| NO307707B1 (no) | Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav | |
| DK243084A (da) | Perkutane farmaceutiske praeparater til udvortes brug | |
| DK539080A (da) | Fremgangsmaade til rensning af taepper og middel til anvendelse herved | |
| DK162986C (da) | 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse | |
| DK332086D0 (da) | Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c | |
| DK40487D0 (da) | Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf | |
| DK114592A (da) | Silibininholdigt farmaceutisk middel | |
| NO860732L (no) | N-(2-klor-4-nitrofenyl)-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette. | |
| DK253785D0 (da) | 2-(heterocyclisk substituerede)-1,4-dihydropyridinderivater samt farmaceutiske praeparater indeholdende disse | |
| DK160816C (da) | Benzoyl-urinstof-derivater, fremgangsmaade til fremstilling af disse, fremgangsmaade til bekaempelse af insektangreb samt insekticidt middel indeholdende disse | |
| DK133587A (da) | 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne | |
| DK234489A (da) | Farmaceutisk praeparat indeholdende et immunosuppressivt middel | |
| DK259586D0 (da) | Farmaceutisk tablet | |
| FR2654341B1 (fr) | Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques. | |
| DK29789D0 (da) | 5-substituerede 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidoner og beslaegtede forbindelser, deres fremstilling og anvendelse som laegemidler | |
| DK164900C (da) | Derivater af 1-(acetylaminophenyl)-2-aminopropanon, et terapeutisk middel indeholdende disse og deres fremstilling | |
| DE3467163D1 (de) | 4-(hydroxyphenylthio)-benzoates | |
| DK75884D0 (da) | Heterocycliske forbindelser, deres syntese, praeparater, der indeholder dem, og deres medicinske anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |